Cancer News and Research

Latest Cancer News and Research

Scientists identify two genetic risk factors for sagittal craniosynostosis

Seattle Children's Research Institute, together with an international team of scientists and clinicians from 22 other institutions, have identified two genetic risk factors for the most common form of non-syndromic craniosynostosis, a birth defect in which the bony plates of an infant's skull prematurely fuse. The condition is known as sagittal craniosynostosis and often results in an abnormal head shape and facial features.

20 Nov 2012

Addition of tomosynthesis to standard mammogram increases breast screening accuracy

The addition of three-dimensional breast imaging-a technology called tomosynthesis-to standard digital mammography significantly increases radiologists' diagnostic accuracy while reducing false positive recall rates, according to the results of a multi-center study published in Radiology.

20 Nov 2012

New solar steam method from Rice University

Rice University scientists have unveiled a revolutionary new technology that uses nanoparticles to convert solar energy directly into steam. The new "solar steam" method from Rice's Laboratory for Nanophotonics (LANP) is so effective it can even produce steam from icy cold water.

20 Nov 2012

USPTO issues Notice of Allowance to Sanovas’ nested balloon catheter

Sanovas, Inc., a life science technology company focused on developing and commercializing the next-generation of micro-invasive diagnostics, devices and drug delivery technologies, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the company's nested balloon catheter for localized drug delivery, a component of Sanovas' Vas Zeppelin Smart Catheter technology portfolio.

20 Nov 2012

Gifts That Give announces partnership with St. Jude Children's Research Hospital

Gifts That Give, Inc., the popular social commerce site with a strong charitable mission, announced its inaugural partnership with St. Jude Children's Research Hospital by joining the St. Jude Thanks and Giving campaign.

20 Nov 2012

Finnish researchers develop triumphant solution to predict breast cancer cells’ responses to drugs

The answer is yes. Finnish researchers have developed a triumphant solution for predicting responses of breast cancer cells to a set of cancer drugs. The prediction is based on the genomic profiles of the cancer cells. Harnessing genomic profiles of cells in choosing the best treatment is considered the holy grail of personalised medicine.

20 Nov 2012

Combination of perifosine and temsirolimus shows promise against malignant glioma

Aeterna Zentaris Inc. today announced that perifosine, its oral AKT inhibitor, combined with temsirolimus ("TEM"), was well tolerated in an investigator driven Phase 1 clinical trial in recurrent or progressive malignant glioma ("MG").

20 Nov 2012

Dune Medical Devices gets FDA PMA Approvable Letter for MarginProbe System

Dune Medical Devices, Inc., announced today that it has received an Approvable Letter for its Premarket Approval Application (PMA) from the Food and Drug Administration. The Approvable Letter states that the MarginProbe System PMA is approvable subject to final agreement with FDA on the design of the required Post Approval Study.

20 Nov 2012

Diffusion Pharmaceuticals completes trans sodium crocetinate Phase I trial on glioblastoma

Diffusion Pharmaceuticals LLC, a biotechnology company developing innovative cancer treatments, today announced that it has successfully completed a Phase I clinical trial of its lead compound trans sodium crocetinate (TSC) in nine patients with newly diagnosed primary brain cancer (glioblastoma or GBM).

19 Nov 2012

Roundup: Wyo. conservatives ponder election; Ill. Insurer to buy Montana Blues; Calif. nurses plan new strike

But since the election, a blanket of baffled worry has descended on conservatives here like early snow across the plains, deepening a sense that traditional, rural and overwhelmingly white states in the center of the country are losing touch with an increasingly diverse and urban American electorate.

19 Nov 2012

Janssen receives positive opinion from EMA CHMP for ZYTIGA to treat mCRPC

Janssen-Cilag International NV (Janssen) announced today that the Committee for Medical Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending approval of the oral, once-daily medication ZYTIGA for use in combination with prednisone or prednisolone in the treatment of metastatic castration-resistant prostate cancer (mCRPC), in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy and in whom chemotherapy is not yet clinically indicated.

19 Nov 2012

Aetna, Glens Falls Hospital announce new multiyear agreement

Glens Falls Hospital and Aetna today announced a new multiyear agreement. Glens Falls will remain an "in-network" provider of care for Aetna members.

19 Nov 2012

Postprostatectomy urinary function assessment tool refined

Researchers have presented a proposed stratification of the urinary incontinence domain of the Expanded Prostate Cancer Index Composite.

19 Nov 2012

Bevacizumab ruled out for stage III colorectal cancer

Findings from the AVANT trial do not support the use of bevacizumab in patients receiving oxaliplatin-based chemotherapy for resected stage III or high-risk stage II colon carcinoma.

19 Nov 2012

Biomolecular imaging: an interview with Professor Roger Reddel

The reason Children’s Medical Research Institute (CMRI) exists is to find ways to treat or prevent childhood disease. Our research programs are focussed on the areas of cancer cell growth, nerve cell signalling, embryology and gene therapy. These four programs have a shared aim of translating novel findings into new treatments for the benefit of families everywhere.

19 Nov 2012

Overexpression of BCL6 results in transformation of neural stem cells into cortical neurons

The cerebral cortex is the most complex structure in our brain and the seat of consciousness, emotion, motor control and language. In order to fulfill these functions, it is composed of a diverse array of nerve cells, called cortical neurons, which are affected by many neurological and neuropsychiatric diseases.

19 Nov 2012

Certain occupations do increase risk of breast cancer

Is there a link between the risk of breast cancer and the working environment? A study published in BioMed Central's open access journal Environmental Health provides further evidence on this previously neglected research topic, confirming that certain occupations do pose a higher risk of breast cancer than others, particularly those that expose the worker to potential carcinogens and endocrine disrupters.

19 Nov 2012

EMUC discusses current and future prospects in imaging for prostate cancer

At the 4th European Multidisciplinary Meeting on Urological Cancers (EMUC) held this weekend in Barcelona, Spain, specialists from radiology, urology, medical oncology and pathology said that new developments and research are already underway but benefits to patients would take some time due to the need for clinical trials, the high cost of funding research and the ability of cancer experts to efficiently take advantage of new insights and approaches, among other challenges.

19 Nov 2012

Four New York students named National Finalists in Siemens Competition

Months of dedication and hard work in science, technology, engineering and mathematics (STEM) paid off tonight for four students named National Finalists in the Siemens Competition in Math, Science & Technology, the nation's premier research competition.

19 Nov 2012

Positive results from Genentech Avastin plus temozolomide Phase III study on glioblastoma

Genentech, a member of the Roche Group, today announced results from the positive Phase III AVAglio study. The study showed Avastin (bevacizumab) in combination with radiation and temozolomide chemotherapy reduced the risk of cancer worsening or death (progression-free survival; PFS) by 36 percent compared to radiation and temozolomide chemotherapy plus placebo>th Annual Meeting of the Society for Neuro-Oncology in Washington, D.C.

19 Nov 2012

Cancer News and Research

Latest Cancer News and Research

Scientists identify two genetic risk factors for sagittal craniosynostosis

Addition of tomosynthesis to standard mammogram increases breast screening accuracy

New solar steam method from Rice University

USPTO issues Notice of Allowance to Sanovas’ nested balloon catheter

Gifts That Give announces partnership with St. Jude Children's Research Hospital

Finnish researchers develop triumphant solution to predict breast cancer cells’ responses to drugs

Combination of perifosine and temsirolimus shows promise against malignant glioma

Dune Medical Devices gets FDA PMA Approvable Letter for MarginProbe System

Diffusion Pharmaceuticals completes trans sodium crocetinate Phase I trial on glioblastoma

Roundup: Wyo. conservatives ponder election; Ill. Insurer to buy Montana Blues; Calif. nurses plan new strike

Janssen receives positive opinion from EMA CHMP for ZYTIGA to treat mCRPC

Aetna, Glens Falls Hospital announce new multiyear agreement

Postprostatectomy urinary function assessment tool refined

Bevacizumab ruled out for stage III colorectal cancer

Biomolecular imaging: an interview with Professor Roger Reddel

Overexpression of BCL6 results in transformation of neural stem cells into cortical neurons

Certain occupations do increase risk of breast cancer

EMUC discusses current and future prospects in imaging for prostate cancer

Four New York students named National Finalists in Siemens Competition

Positive results from Genentech Avastin plus temozolomide Phase III study on glioblastoma

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in